Publications

Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenstrom's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenstrom's Macroglobulinemia

AuthID
P-00Y-THG

Author(s)

Buske, C

Dimopoulos, MA

Grunenberg, A

Kastritis, E

Tomowiak, C

Mahe, B

Troussard, X

Hajek, R

Viardot, A

Tournilhac, O

[+5]·

de Guibert, S

Brandefors, L

Garcia Sanz, R

da Silva, MG

Kimby, E

Schmelzle, B

Kaszynski, D

Dreyhaupt, J

Muche, R

Morel, P

View all authors

Document Type

Article

Year published

2023

Published

in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X

Volume: 41, Issue: 14, Pages: 2607-+ (11)

Indexing

Wos^®

Crossref^®17

Pubmed^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1200/jco.22.01805

Pubmed: 36763945

Wos: WOS:001009704600020

Source Identifiers

ISSN: 0732-183X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

All authors

Name Order	Name	Name Order	Name	Name Order	Name
1	Buske, C;	2	Dimopoulos, MA;	3	Grunenberg, A;
4	Kastritis, E;	5	Tomowiak, C;	6	Mahe, B;
7	Troussard, X;	8	Hajek, R;	9	Viardot, A;
10	Tournilhac, O;	11	Aurran, T;	12	Lepretre, S;
13	Zerazhi, H;	14	Hivert, B;	15	Leblond, V;
16	de Guibert, S;	17	Brandefors, L;	18	Garcia Sanz, R;
19	da Silva, MG;	20	Kimby, E;	21	Schmelzle, B;
22	Kaszynski, D;	23	Dreyhaupt, J;	24	Muche, R;
25	Morel, P;

Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenstrom's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenstrom's Macroglobulinemia

Useful Links

Get Help

Federated Authentication (Click on the image)

Bortezomib-Dexamethasone, Rituximab, and Cyclophosphamide as First-Line Treatment for Waldenstrom's Macroglobulinemia: A Prospectively Randomized Trial of the European Consortium for Waldenstrom's Macroglobulinemia

Useful Links

Get Help